These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 12386917)
1. Association between prostate cancer and serum testosterone levels. Zhang PL; Rosen S; Veeramachaneni R; Kao J; DeWolf WC; Bubley G Prostate; 2002 Nov; 53(3):179-82. PubMed ID: 12386917 [TBL] [Abstract][Full Text] [Related]
2. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
3. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer? Lackner JE; Maerk I; Koller A; Bieglmayer C; Marberger M; Kratzik C; Schatzl G Urology; 2008 Nov; 72(5):1121-4. PubMed ID: 18407338 [TBL] [Abstract][Full Text] [Related]
4. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. Teloken C; Da Ros CT; Caraver F; Weber FA; Cavalheiro AP; Graziottin TM J Urol; 2005 Dec; 174(6):2178-80. PubMed ID: 16280759 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Morgentaler A; Rhoden EL Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647 [TBL] [Abstract][Full Text] [Related]
6. Is low serum free testosterone a marker for high grade prostate cancer? Hoffman MA; DeWolf WC; Morgentaler A J Urol; 2000 Mar; 163(3):824-7. PubMed ID: 10687985 [TBL] [Abstract][Full Text] [Related]
7. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. Morote J; Ramirez C; Gómez E; Planas J; Raventós CX; de Torres IM; Catalán R BJU Int; 2009 Aug; 104(4):486-9. PubMed ID: 19220251 [TBL] [Abstract][Full Text] [Related]
8. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy. Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136 [TBL] [Abstract][Full Text] [Related]
9. Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients? Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Naya Y; Shiraishi T; Ichikawa T Prostate Cancer Prostatic Dis; 2009; 12(1):78-82. PubMed ID: 18521100 [TBL] [Abstract][Full Text] [Related]
10. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study. Pathak AS; Pacificar JS; Shapiro CE; Williams SG J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298 [TBL] [Abstract][Full Text] [Related]
11. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer. Dai B; Qu Y; Kong Y; Ye D; Yao X; Zhang S; Wang C; Zhang H; Yang W BJU Int; 2012 Dec; 110(11 Pt B):E667-72. PubMed ID: 22974446 [TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Sarosdy MF Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557 [TBL] [Abstract][Full Text] [Related]
13. Absence of relationship between steroid hormone levels and prostate cancer tumor grade. Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418 [TBL] [Abstract][Full Text] [Related]
14. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL. Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074 [TBL] [Abstract][Full Text] [Related]
15. High-grade prostate cancer is associated with low serum testosterone levels. Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729 [TBL] [Abstract][Full Text] [Related]
16. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Tahir SA; Frolov A; Hayes TG; Mims MP; Miles BJ; Lerner SP; Wheeler TM; Ayala G; Thompson TC; Kadmon D Clin Cancer Res; 2006 Aug; 12(16):4872-5. PubMed ID: 16914574 [TBL] [Abstract][Full Text] [Related]
17. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men. Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. Massengill JC; Sun L; Moul JW; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Donahue T J Urol; 2003 May; 169(5):1670-5. PubMed ID: 12686805 [TBL] [Abstract][Full Text] [Related]
19. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml. Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888 [TBL] [Abstract][Full Text] [Related]
20. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]